PACB vs UBER · rev $38.4M vs P/E 18, rev $52.02B
Pacific Biosciences of California (PACB) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
PACB currently screens at market cap $387.1M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the PACB and UBER stock pages for the full models.
Not investment advice.